Created at Source Raw Value Validated value
June 25, 2024, noon usa

a. inclusion criteria: 1. minimum 18 - 80 years of age 2. clinical diagnosis of covid 19 with rt-pcr test for sars-cov-2 (if a patient is covid19 positive based on antigen test, they can participate in the trial while awaiting result form pcr test with ct-value) 3. signed informed consent provided by patient's or patient's healthcare proxy. 4. fulfills enrollment criteria ( within 6 days of symptoms onset) 5. willing to practice celibacy or take contraception during the study \& within 7 days after treatment 6. mild clinical condition with at least 3 of these of these symptoms : fever, cough, malaise/headache 7. moderate clinical condition with at least 3 of these of these symptoms : fever, cough, malaise/headache b.

a. inclusion criteria: 1. minimum 18 - 80 years of age 2. clinical diagnosis of covid 19 with rt-pcr test for sars-cov-2 (if a patient is covid19 positive based on antigen test, they can participate in the trial while awaiting result form pcr test with ct-value) 3. signed informed consent provided by patient's or patient's healthcare proxy. 4. fulfills enrollment criteria ( within 6 days of symptoms onset) 5. willing to practice celibacy or take contraception during the study \& within 7 days after treatment 6. mild clinical condition with at least 3 of these of these symptoms : fever, cough, malaise/headache 7. moderate clinical condition with at least 3 of these of these symptoms : fever, cough, malaise/headache b.

Nov. 16, 2021, 6:30 p.m. usa

a. inclusion criteria: minimum 18 - 80 years of age clinical diagnosis of covid 19 with rt-pcr test for sars-cov-2 (if a patient is covid19 positive based on antigen test, they can participate in the trial while awaiting result form pcr test with ct-value) signed informed consent provided by patient's or patient's healthcare proxy. fulfills enrollment criteria ( within 6 days of symptoms onset) willing to practice celibacy or take contraception during the study & within 7 days after treatment mild clinical condition with at least 3 of these of these symptoms : fever, cough, malaise/headache moderate clinical condition with at least 3 of these of these symptoms : fever, cough, malaise/headache b.

a. inclusion criteria: minimum 18 - 80 years of age clinical diagnosis of covid 19 with rt-pcr test for sars-cov-2 (if a patient is covid19 positive based on antigen test, they can participate in the trial while awaiting result form pcr test with ct-value) signed informed consent provided by patient's or patient's healthcare proxy. fulfills enrollment criteria ( within 6 days of symptoms onset) willing to practice celibacy or take contraception during the study & within 7 days after treatment mild clinical condition with at least 3 of these of these symptoms : fever, cough, malaise/headache moderate clinical condition with at least 3 of these of these symptoms : fever, cough, malaise/headache b.

Jan. 6, 2021, 12:31 a.m. usa

a. inclusion criteria: 1. minimum 18 - 80 years of age 2. clinical diagnosis of covid 19 with rt-pcr test for sars-cov-2 (if a patient is covid19 positive based on antigen test, they can participate in the trial while awaiting result form pcr test with ct-value) 3. signed informed consent provided by patient's or patient's healthcare proxy. 4. fulfills enrollment criteria ( within 6 days of symptoms onset) 5. willing to practice celibacy or take contraception during the study & within 7 days after treatment 6. mild clinical condition with at least 3 of these of these symptoms : fever, cough, malaise/headache 7. moderate clinical condition with at least 3 of these of these symptoms : fever, cough, malaise/headache b.

a. inclusion criteria: 1. minimum 18 - 80 years of age 2. clinical diagnosis of covid 19 with rt-pcr test for sars-cov-2 (if a patient is covid19 positive based on antigen test, they can participate in the trial while awaiting result form pcr test with ct-value) 3. signed informed consent provided by patient's or patient's healthcare proxy. 4. fulfills enrollment criteria ( within 6 days of symptoms onset) 5. willing to practice celibacy or take contraception during the study & within 7 days after treatment 6. mild clinical condition with at least 3 of these of these symptoms : fever, cough, malaise/headache 7. moderate clinical condition with at least 3 of these of these symptoms : fever, cough, malaise/headache b.